Researcher comment: The DISCOVER-2 trial (with Philip Mease)
Lead investigator Philip Mease outlines the results of the DISCOVER-2 trial, and discusses how guselkumab may impact the psoriatic arthritis treatment landscape.
Find more on Medicine Matters rheumatology
More from the 2019 ACR/ARP Annual Meeting
Create your
podcast in
minutes
It is Free